Prolactin Regulation of Kisspeptin Neurones in the Mouse Brain and its Role in the Lactation-Induced Suppression of Kisspeptin Expression

• Published in: Journal of neuroendocrinology Vol. 26; no. 12; pp. 898 - 908
• Main Authors: Brown, R. S. E., Herbison, A. E., Grattan, D. R.
• Format: Journal Article
• Language: English
• Published: United States Blackwell Publishing Ltd 01-12-2014; Wiley Subscription Services, Inc
• Subjects: Animals; Arcuate Nucleus of Hypothalamus - metabolism; Brain - cytology; Brain - drug effects; Brain - metabolism; Bromocriptine - pharmacology; Female; GnRH; Gonadotropin-Releasing Hormone; kisspeptin; Kisspeptins - biosynthesis; Kisspeptins - metabolism; lactation; Lactation - physiology; Luteinizing Hormone - blood; Mice; Neurons - drug effects; Neurons - metabolism; Nipples - surgery; prolactin; Prolactin - pharmacology; Prolactin - physiology; STAT5 Transcription Factor - metabolism; Third Ventricle - drug effects; Third Ventricle - metabolism; prolactin; GnRH; LH; kisspeptin; lactation
• ISSN: 0953-8194; 1365-2826
• DOI: 10.1111/jne.12223

Hyperprolactinaemia is a major cause of infertility in both males and females, although the mechanism by which prolactin inhibits the reproductive axis is not clear. The aim of the present study was to test the hypothesis that elevated prolactin causes suppression of kisspeptin expression in the hypothalamus, resulting in reduced release of gonadotrophin‐releasing hormone (GnRH) and consequent infertility. In oestrogen‐treated ovariectomised mice, chronic prolactin‐treatment prevented the rise in luteinising hormone (LH) seen in vehicle‐treated mice. Kiss1 mRNA was significantly suppressed in both the rostral periventricular region of the third ventricle (RP3V) and arcuate nucleus after prolactin treatment. Exogenous prolactin treatment induced phosphorylated signal transducer and activator of transcription 5 (pSTAT5) in kisspeptin neurones, and suppression of endogenous prolactin using bromocriptine reduced levels of pSTAT5 in kisspeptin neurones, suggesting that prolactin acts directly on kisspeptin neurones. By contrast, fewer than 1% of GnRH neurones expressed pSTAT5 in either dioestrous or lactating mice. As reported previously, there was significant suppression of kisspeptin mRNA and protein in the RP3V on day 7 of lactation, although not in the arcuate nucleus. Bromocriptine treatment significantly increased Kiss1 mRNA expression in the RP3V, although not to dioestrous levels. Unilateral thelectomy, aiming to eliminate sensory inputs from nipples on one side of the body, failed to alter the reduction in the number of kisspeptin neurones observed in the RP3V. These data demonstrate that chronic prolactin administration suppressed serum LH, and reduced Kiss1 mRNA levels in both the RP3V and arcuate nucleus, consistent with the hypothesis that prolactin‐induced suppression of kisspeptin secretion might mediate the inhibitory effects of prolactin on GnRH secretion. During lactation, however, the suppression of Kiss1 mRNA in the RP3V was only partially reversed by the administration of bromocriptine to block elevated levels of prolactin, suggesting that, although elevated prolactin contributes to lactational anovulation, additional non‐neural factors must also contribute to the lactation‐induced suppression of kisspeptin neurones.